687 related articles for article (PubMed ID: 25744769)
21. Novel Insights Into E3 Ubiquitin Ligase in Cancer Chemoresistance.
Yang L; Chen J; Huang X; Zhang E; He J; Cai Z
Am J Med Sci; 2018 Apr; 355(4):368-376. PubMed ID: 29661351
[TBL] [Abstract][Full Text] [Related]
22. [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].
Yu Q; Xiong X; Sun Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):1-19. PubMed ID: 32621419
[TBL] [Abstract][Full Text] [Related]
23. Cullin-RING Ligases as attractive anti-cancer targets.
Zhao Y; Sun Y
Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics.
Shafique S; Ali W; Kanwal S; Rashid S
Int J Biol Macromol; 2018 Jan; 106():532-543. PubMed ID: 28802844
[TBL] [Abstract][Full Text] [Related]
25. Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery.
Hussain M; Lu Y; Liu YQ; Su K; Zhang J; Liu J; Zhou GB
Pharmacol Res; 2016 Sep; 111():34-42. PubMed ID: 27238229
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of Fbw7 in human melanoma and its role in cell migration.
Cheng Y; Chen G; Martinka M; Ho V; Li G
J Invest Dermatol; 2013 Jul; 133(7):1794-802. PubMed ID: 23381582
[TBL] [Abstract][Full Text] [Related]
27. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
[TBL] [Abstract][Full Text] [Related]
28. Targeting neddylation in cancer therapy.
Duncan K; Schäfer G; Vava A; Parker MI; Zerbini LF
Future Oncol; 2012 Nov; 8(11):1461-70. PubMed ID: 23148618
[TBL] [Abstract][Full Text] [Related]
29. Targeted modulation of E3 ligases using engineered ubiquitin variants.
LeBlanc N; Mallette E; Zhang W
FEBS J; 2021 Apr; 288(7):2143-2165. PubMed ID: 32867007
[TBL] [Abstract][Full Text] [Related]
30. Two distinct E3 ligases, SCF
Liu J; Dong S; Wang H; Li L; Ye Q; Li Y; Miao J; Jhiang S; Zhao J; Zhao Y
FASEB J; 2019 Sep; 33(9):10538-10550. PubMed ID: 31238008
[TBL] [Abstract][Full Text] [Related]
31. F-box proteins: the key to protein degradation.
Ho MS; Tsai PI; Chien CT
J Biomed Sci; 2006 Mar; 13(2):181-91. PubMed ID: 16463014
[TBL] [Abstract][Full Text] [Related]
32. Role of F-box E3-ubiquitin ligases in plant development and stress responses.
Saxena H; Negi H; Sharma B
Plant Cell Rep; 2023 Jul; 42(7):1133-1146. PubMed ID: 37195503
[TBL] [Abstract][Full Text] [Related]
33. Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle.
Dogan T; Gnad F; Chan J; Phu L; Young A; Chen MJ; Doll S; Stokes MP; Belvin M; Friedman LS; Kirkpatrick DS; Hoeflich KP; Hatzivassiliou G
J Biol Chem; 2017 Sep; 292(35):14311-14324. PubMed ID: 28655764
[TBL] [Abstract][Full Text] [Related]
34. Cullin-RING Ligases as Promising Targets for Gastric Carcinoma Treatment.
Song Q; Feng S; Peng W; Li A; Ma T; Yu B; Liu HM
Pharmacol Res; 2021 Aug; 170():105493. PubMed ID: 33600940
[TBL] [Abstract][Full Text] [Related]
35. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases.
Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR
J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574
[TBL] [Abstract][Full Text] [Related]
36. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
37. Targeting E3 Ubiquitin Ligases and Deubiquitinases in Ciliopathy and Cancer.
Shiromizu T; Yuge M; Kasahara K; Yamakawa D; Matsui T; Bessho Y; Inagaki M; Nishimura Y
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825105
[TBL] [Abstract][Full Text] [Related]
38. Approaches to discovering drugs that regulate E3 ubiquitin ligases.
Huang J; Tsvetkov L; Qu K; Daniel-Issakani S; Payan DG
Ernst Schering Found Symp Proc; 2008; (1):153-70. PubMed ID: 19198069
[TBL] [Abstract][Full Text] [Related]
39. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
[TBL] [Abstract][Full Text] [Related]
40. Editorial: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer Therapy.
Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):100. PubMed ID: 26791134
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
